Influenza A - H1N1 (swine flu)
H1N1 flu virus information, news and statistics as of Wednesday March 10, 2010
Worldwide H1N1
Tracking & Statistics

Wednesday March 10, 2010

2,475
H1N1 fatalities
in 62 countries

Click on country for details

Afghanistan
Albania
Algeria
Andorra
Antigua and Barbuda
Argentina
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belgium
Belize
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
British Virgin Islands
Brunei Darussalam
Bulgaria
Cambodia
Canada
Cap Verde
Cayman Islands
Channel Islands
Chile
China
Colombia
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guyana
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kosovo
Kuwait
Laos
Latvia
Lebanon
Libya
Liechtenstein
Lithuania
Luxembourg
Macedonia
Malaysia
Maldives
Malta
Marshall Islands
Martinique
Mauritius
Mexico
Micronesia
Moldova
Monaco
Montenegro
Morocco
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Romania
Russia
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Vincent
Samoa
Saudi Arabia
Serbia
Seychelles
Singapore
Slovakia
Slovenia
Solomon Islands
South Africa
South Korea
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tanzania
Thailand
Tonga
Trinidad and Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Vanuatu
Venezuela
Vietnam
West Bank Gaza Strip
Yemen

Source: World Health Organization


good-natured
Obama
Jokes


United States H1N1
Tracking & Statistics
Wednesday March 10, 2010
43,771 infections
302 deaths
in all 50 US States
plus Washington DC and Territories
Click on state for details
Alabama
Alaska
American Samoa
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Guam
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virgin Islands
Virginia
Washington
West Virginia
Wisconsin
Wyoming

Source: CDC


WORLD HEALTH
ORGANIZATION

Pandemic Alert
Phase 6
more on Pandemic Alerts

Untitled Document



H1N1 (swine flu) treatment


H1N1 (swine flu) Antiviral Drugs

Antiviral drugs are prescription medicines (pills, liquid or an inhaler) with activity against influenza viruses, including H1N1 influenza A viruses. Antiviral drugs can be used to treat H1N1 flu or to prevent infection with H1N1 flu viruses. These medications must be prescribed by a health care professional. Influenza antiviral drugs only work against influenza viruses -- they will not help treat or prevent symptoms caused by infection from other viruses that can cause symptoms similar to the flu.

There are four influenza antiviral drugs approved for use in the United States (oseltamivir, zanamivir, amantadine and rimantadine). The influenza A (H1N1) viruses that have been detected in humans in the United States and Mexico are resistant to amantadine and rimantadine so these drugs will not work against these H1N1 influenza viruses. Laboratory testing on these influenza A (H1N1) viruses so far indicate that they are susceptible (sensitive) to oseltamivir and zanamivir.

Benefits of H1N1 (swine flu) Antiviral Drugs

Treatment:

If you get sick, antiviral drugs can make your illness milder and make you feel better faster. They may also prevent serious influenza complications. Influenza antiviral drugs work best when started soon after illness onset (within two 2 days), but treatment with antiviral drugs should still be considered after 48 hours of symptom onset, particularly for hospitalized patients or people at high risk for influenza-related complications.

Prevention:

Influenza antiviral drugs also can be used to prevent influenza when they are given to a person who is not ill, but who has been or may be near a person with swine influenza. When used to prevent the flu, antiviral drugs are about 70% to 90% effective. When used for prevention, the number of days that they should be used will vary depending on a person’s particular situation.

CDC Recommendation

CDC recommends the use of oseltamivir or zanamivir for the treatment and/or prevention of infection with swine influenza viruses.

Oseltamivir (brand name Tamiflu ®) is approved to both treat and prevent influenza A and B virus infection in people one year of age and older.

Zanamivir (brand name Relenza ®) is approved to treat influenza A and B virus infection in people 7 years and older and to prevent influenza A and B virus infection in people 5 years and older.

Recommendations for using antiviral drugs for treatment or prevention of swine influenza will change as we learn more about this new virus.

Clinicians should consider treating any person with confirmed or suspected swine influenza with an antiviral drug.

Visit: http://www.cdc.gov/h1n1flu/recommendations.htm for specific recommendations.

Fequently asked questions (FAQ) about H1N1 (swine flu)

 

 

 

H1N1 Copyright © 2010 H1N1.Flu-Virus.org This site is not authorized by the CDC, ECDC, PHAC, WHO or any other health organization whether national, state or local. Any trademarks appearing on this site are the property of their respective owners.
H1N1.Flu-Virus.org is a compilation of information which, to the best of our ability, is accurate and up to date. The great majority of the information contained within is compiled from the official websites of national and international health organizations. Please seek the advice of professionals, as appropriate, regarding the evaluation of any specific information, opinion, advice or other content on this site. Contact us at A@H-1-N-1.org